Stay updated on TSR-033 & Anti-PD-1 in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the TSR-033 & Anti-PD-1 in Solid Tumors Clinical Trial page.

Latest updates to the TSR-033 & Anti-PD-1 in Solid Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedMajor change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).SummaryDifference10%
- Check20 days agoChange DetectedThe page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.SummaryDifference0.2%
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page now shows Revision: v3.0.2, replacing v3.0.1, and the 'Back to Top' element was removed. No changes to core content, pricing, stock, or time slots.SummaryDifference0.6%
- Check41 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.6%
- Check49 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information. This suggests a shift towards a more generalized presentation of the study's location.SummaryDifference35%
- Check63 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.3%
Stay in the know with updates to TSR-033 & Anti-PD-1 in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TSR-033 & Anti-PD-1 in Solid Tumors Clinical Trial page.